Azenta, Inc. (AZTA)
NASDAQ: AZTA · IEX Real-Time Price · USD
51.53
+0.49 (0.96%)
Jul 2, 2024, 4:00 PM EDT - Market closed
Azenta Employees
Azenta had 3,500 employees as of September 30, 2023. The number of employees increased by 400 or 12.90% compared to the previous year.
Employees
3,500
Change (1Y)
400
Growth (1Y)
12.90%
Revenue / Employee
$186,216
Profits / Employee
-$43,057
Market Cap
2.78B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Sep 30, 2023 | 3,500 | 400 | 12.90% |
Sep 30, 2022 | 3,100 | 300 | 10.71% |
Sep 30, 2021 | 2,800 | -359 | -11.36% |
Sep 30, 2020 | 3,159 | 175 | 5.86% |
Sep 30, 2019 | 2,984 | 1,436 | 92.76% |
Sep 30, 2018 | 1,548 | -113 | -6.80% |
Sep 30, 2017 | 1,661 | 351 | 26.79% |
Sep 30, 2016 | 1,310 | -116 | -8.13% |
Sep 30, 2015 | 1,426 | -29 | -1.99% |
Sep 30, 2014 | 1,455 | -16 | -1.09% |
Sep 30, 2013 | 1,471 | 44 | 3.08% |
Sep 30, 2012 | 1,427 | -6 | -0.42% |
Sep 30, 2011 | 1,433 | 23 | 1.63% |
Sep 30, 2010 | 1,410 | 212 | 17.70% |
Sep 30, 2009 | 1,198 | -460 | -27.74% |
Sep 30, 2008 | 1,658 | -242 | -12.74% |
Sep 30, 2007 | 1,900 | -500 | -20.83% |
Sep 30, 2006 | 2,400 | 600 | 33.33% |
Sep 30, 2005 | 1,800 | -100 | -5.26% |
Sep 30, 2004 | 1,900 | 0 | - |
Sep 30, 2003 | 1,900 | -1,100 | -36.67% |
Sep 30, 2002 | 3,000 | 1,100 | 57.89% |
Sep 30, 2001 | 1,900 | 300 | 18.75% |
Sep 30, 2000 | 1,600 | 750 | 88.24% |
Sep 30, 1999 | 850 | 355 | 71.72% |
Sep 30, 1998 | 495 | -23 | -4.44% |
Sep 30, 1997 | 518 | 59 | 12.85% |
Sep 30, 1996 | 459 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
ICU Medical | 14,000 |
Envista Holdings | 12,800 |
LivaNova | 2,900 |
Twist Bioscience | 919 |
Progyny | 566 |
MorphoSys AG | 524 |
TG Therapeutics | 264 |
Xenon Pharmaceuticals | 259 |
AZTA News
- 4 weeks ago - Azenta Announces Collaboration with the Crohn's & Colitis Foundation to Support its Crohn's Disease and Ulcerative Colitis Clinical Research - PRNewsWire
- 5 weeks ago - Azenta to Participate in the Jefferies Global Healthcare Conference - PRNewsWire
- 7 weeks ago - Azenta Opens the Doors to Its New Genomics Laboratory in Oxford, UK - PRNewsWire
- 7 weeks ago - Azenta Announces CEO Succession Plan - PRNewsWire
- 7 weeks ago - Azenta Reports Second Quarter Results for Fiscal 2024, Ended March 31, 2024 - PRNewsWire
- 2 months ago - Azenta Announces Fiscal 2024 Second Quarter Earnings Conference Call and Webcast - PRNewsWire
- 3 months ago - Azenta Publishes its 2023 Environmental, Social, & Governance (ESG) Report - PRNewsWire
- 3 months ago - Azenta to Participate in the 23rd Annual Needham Virtual Healthcare Conference - PRNewsWire